These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 38161090
1. The Effectiveness of Deflux® Treatment for Vesicoureteral Reflux Following Pediatric Renal Transplantation: A Single-Institution Challenging Experience. Obata S, Nagata K, Suematsu S, Nishiyama K, Okabe Y, Kondo T, Maniwa J, Fukuta A, Kawakubo N, Yanagi Y, Miyata J, Matsuura T, Ohga S, Nakamura M, Tajiri T. J Pediatr Surg; 2024 Apr; 59(4):616-620. PubMed ID: 38161090 [Abstract] [Full Text] [Related]
2. A systematic review of outcomes of Deflux® treatment for vesicoureteral reflux following pediatric renal transplantation. Rebullar K, O'Kelly F, Koyle MA, Kirsch A, Al-Kutbi R, Zu'bi F. J Pediatr Urol; 2021 Aug; 17(4):589.e1-589.e6. PubMed ID: 34364813 [Abstract] [Full Text] [Related]
3. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population. Sheth KR, White JT, Stanasel I, Janzen N, Mittal A, Koh CJ, Austin PF, Roth DR, Tu DD, Gonzales ET, Ryan S, Jorgez C, Seth A. J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426 [Abstract] [Full Text] [Related]
4. The deflux procedure reduces the incidence of urinary tract infections in patients with vesicoureteral reflux. Wadie GM, Tirabassi MV, Courtney RA, Moriarty KP. J Laparoendosc Adv Surg Tech A; 2007 Jun; 17(3):353-9. PubMed ID: 17570788 [Abstract] [Full Text] [Related]
5. [CLINICAL EXPERIENCE OF TRANSURETHRAL INJECTION USING DEXTRANOMER-HYALURONIC ACID COPOLYMER (Deflux®) FOR CASES OF SECONDARY VESICOURETERAL REFLUX AFTER URETEROCYSTONEOSTOMY]. Aoki Y, Matsui Z, Sato A, Morizawa Y, Iwasa S, Satoh H. Nihon Hinyokika Gakkai Zasshi; 2021 Jun; 112(2):75-80. PubMed ID: 35444085 [Abstract] [Full Text] [Related]
6. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter? Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S. J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422 [Abstract] [Full Text] [Related]
11. Interventions for primary vesicoureteric reflux. Williams G, Hodson EM, Craig JC. Cochrane Database Syst Rev; 2019 Feb 20; 2(2):CD001532. PubMed ID: 30784039 [Abstract] [Full Text] [Related]
12. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population? Chertin B, Mele E, Kocherov S, Zilber S, Gerocarni Nappo S, Capozza N. J Pediatr Urol; 2018 Dec 20; 14(6):538.e1-538.e7. PubMed ID: 29885870 [Abstract] [Full Text] [Related]
13. A novel endoscopic approach for management of hutch diverticulum concomitant vesicoureteral reflux with dextranomer/hyaluronic acid copolymer injection. Pourabhari Langroudi A, Shokri Varniab Z, Nabavizadeh B, Neishabouri A, Kajbafzadeh AM. J Pediatr Urol; 2023 Jun 20; 19(3):321.e1-321.e7. PubMed ID: 36934033 [Abstract] [Full Text] [Related]
18. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney. Ross I, Ahn HJ, Roelof B, Barber T, Huynh V, Rockette A, Popovic M, Chen JJ, Steinhardt G. J Pediatr Urol; 2015 Jun 20; 11(3):145.e1-6. PubMed ID: 25864614 [Abstract] [Full Text] [Related]